
Blood coagulation or clotting is the process by which blood changes from liquid to gel, thus, forming clots. These clots result in cessation of bleeding. However, the process of coagulation is hindered in the people suffering from liver disease, thrombophilia, and hemophilia. Various blood coagulation testing procedures are used for diagnosing these diseases, which provide the status of the hemostatic functioning of the patient. Haemostatic involves a coordinated series of interactions between platelets and numerous blood clotting proteins. With increasing prevalence of hemostatic diseases, the demand for blood coagulation testing has increased. To analyses the treatment efficiency against hemostatic diseases, the blood clotting testing is required.
The global market for Blood Coagulation Testing was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Blood Coagulation Testing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood Coagulation Testing by region & country, by Type, and by Application.
The Blood Coagulation Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Coagulation Testing.
Market Segmentation
By Company
Roche
Abbott
Siemens Healthcare
Accriva Diagnostics
CoaguSense
HomoSonics
iLine Microsystems
Instrumentation Laboratory
Sienco
SenGenix
Bio/Data Corporation
Segment by Type:
Clinical Laboratory
Automated
Segment by Application
Academic Institutions
Hospitals
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Blood Coagulation Testing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Blood Coagulation Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Blood Coagulation Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Blood Coagulation Testing Product Introduction
1.2 Global Blood Coagulation Testing Market Size Forecast
1.3 Blood Coagulation Testing Market Trends & Drivers
1.3.1 Blood Coagulation Testing Industry Trends
1.3.2 Blood Coagulation Testing Market Drivers & Opportunity
1.3.3 Blood Coagulation Testing Market Challenges
1.3.4 Blood Coagulation Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Blood Coagulation Testing Players Revenue Ranking (2023)
2.2 Global Blood Coagulation Testing Revenue by Company (2019-2024)
2.3 Key Companies Blood Coagulation Testing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Blood Coagulation Testing Product Offered
2.5 Key Companies Time to Begin Mass Production of Blood Coagulation Testing
2.6 Blood Coagulation Testing Market Competitive Analysis
2.6.1 Blood Coagulation Testing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Blood Coagulation Testing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Coagulation Testing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Clinical Laboratory
3.1.2 Automated
3.2 Global Blood Coagulation Testing Sales Value by Type
3.2.1 Global Blood Coagulation Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Blood Coagulation Testing Sales Value, by Type (2019-2030)
3.2.3 Global Blood Coagulation Testing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Academic Institutions
4.1.2 Hospitals
4.2 Global Blood Coagulation Testing Sales Value by Application
4.2.1 Global Blood Coagulation Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Blood Coagulation Testing Sales Value, by Application (2019-2030)
4.2.3 Global Blood Coagulation Testing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Blood Coagulation Testing Sales Value by Region
5.1.1 Global Blood Coagulation Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Blood Coagulation Testing Sales Value by Region (2019-2024)
5.1.3 Global Blood Coagulation Testing Sales Value by Region (2025-2030)
5.1.4 Global Blood Coagulation Testing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Blood Coagulation Testing Sales Value, 2019-2030
5.2.2 North America Blood Coagulation Testing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Blood Coagulation Testing Sales Value, 2019-2030
5.3.2 Europe Blood Coagulation Testing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Blood Coagulation Testing Sales Value, 2019-2030
5.4.2 Asia Pacific Blood Coagulation Testing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Blood Coagulation Testing Sales Value, 2019-2030
5.5.2 South America Blood Coagulation Testing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Blood Coagulation Testing Sales Value, 2019-2030
5.6.2 Middle East & Africa Blood Coagulation Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Blood Coagulation Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Blood Coagulation Testing Sales Value
6.3 United States
6.3.1 United States Blood Coagulation Testing Sales Value, 2019-2030
6.3.2 United States Blood Coagulation Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Blood Coagulation Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Blood Coagulation Testing Sales Value, 2019-2030
6.4.2 Europe Blood Coagulation Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Blood Coagulation Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Blood Coagulation Testing Sales Value, 2019-2030
6.5.2 China Blood Coagulation Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Blood Coagulation Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Blood Coagulation Testing Sales Value, 2019-2030
6.6.2 Japan Blood Coagulation Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Blood Coagulation Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Blood Coagulation Testing Sales Value, 2019-2030
6.7.2 South Korea Blood Coagulation Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Blood Coagulation Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Blood Coagulation Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Blood Coagulation Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Blood Coagulation Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Blood Coagulation Testing Sales Value, 2019-2030
6.9.2 India Blood Coagulation Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Blood Coagulation Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Profile
7.1.2 Roche Main Business
7.1.3 Roche Blood Coagulation Testing Products, Services and Solutions
7.1.4 Roche Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.1.5 Roche Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Blood Coagulation Testing Products, Services and Solutions
7.2.4 Abbott Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Siemens Healthcare
7.3.1 Siemens Healthcare Profile
7.3.2 Siemens Healthcare Main Business
7.3.3 Siemens Healthcare Blood Coagulation Testing Products, Services and Solutions
7.3.4 Siemens Healthcare Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.3.5 Accriva Diagnostics Recent Developments
7.4 Accriva Diagnostics
7.4.1 Accriva Diagnostics Profile
7.4.2 Accriva Diagnostics Main Business
7.4.3 Accriva Diagnostics Blood Coagulation Testing Products, Services and Solutions
7.4.4 Accriva Diagnostics Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.4.5 Accriva Diagnostics Recent Developments
7.5 CoaguSense
7.5.1 CoaguSense Profile
7.5.2 CoaguSense Main Business
7.5.3 CoaguSense Blood Coagulation Testing Products, Services and Solutions
7.5.4 CoaguSense Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.5.5 CoaguSense Recent Developments
7.6 HomoSonics
7.6.1 HomoSonics Profile
7.6.2 HomoSonics Main Business
7.6.3 HomoSonics Blood Coagulation Testing Products, Services and Solutions
7.6.4 HomoSonics Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.6.5 HomoSonics Recent Developments
7.7 iLine Microsystems
7.7.1 iLine Microsystems Profile
7.7.2 iLine Microsystems Main Business
7.7.3 iLine Microsystems Blood Coagulation Testing Products, Services and Solutions
7.7.4 iLine Microsystems Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.7.5 iLine Microsystems Recent Developments
7.8 Instrumentation Laboratory
7.8.1 Instrumentation Laboratory Profile
7.8.2 Instrumentation Laboratory Main Business
7.8.3 Instrumentation Laboratory Blood Coagulation Testing Products, Services and Solutions
7.8.4 Instrumentation Laboratory Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.8.5 Instrumentation Laboratory Recent Developments
7.9 Sienco
7.9.1 Sienco Profile
7.9.2 Sienco Main Business
7.9.3 Sienco Blood Coagulation Testing Products, Services and Solutions
7.9.4 Sienco Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.9.5 Sienco Recent Developments
7.10 SenGenix
7.10.1 SenGenix Profile
7.10.2 SenGenix Main Business
7.10.3 SenGenix Blood Coagulation Testing Products, Services and Solutions
7.10.4 SenGenix Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.10.5 SenGenix Recent Developments
7.11 Bio/Data Corporation
7.11.1 Bio/Data Corporation Profile
7.11.2 Bio/Data Corporation Main Business
7.11.3 Bio/Data Corporation Blood Coagulation Testing Products, Services and Solutions
7.11.4 Bio/Data Corporation Blood Coagulation Testing Revenue (US$ Million) & (2019-2024)
7.11.5 Bio/Data Corporation Recent Developments
8 Industry Chain Analysis
8.1 Blood Coagulation Testing Industrial Chain
8.2 Blood Coagulation Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Blood Coagulation Testing Sales Model
8.5.2 Sales Channel
8.5.3 Blood Coagulation Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Roche
Abbott
Siemens Healthcare
Accriva Diagnostics
CoaguSense
HomoSonics
iLine Microsystems
Instrumentation Laboratory
Sienco
SenGenix
Bio/Data Corporation
Ìý
Ìý
*If Applicable.
